$2.33
-0.08 (-3.32%)
MannKind Corp (NASDAQ:MNKD)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.